Lymph nodes (LNs) are important hubs for metastatic cell arrest and growth, immune
modulation, and secondary dissemination to distant sites through a series of mechanisms …

Background Although incidence and mortality of lung cancer have been decreasing, health
disparities persist among historically marginalized Black, Hispanic, and Asian populations. A …

Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths in the US and
worldwide. In particular, vulnerable populations such as those of low socioeconomic status …

Patients with progressive fibrosing interstitial lung diseases (fILD) have increased morbidity
and mortality. Lung fibrosis can be associated with lung cancer. The pathogenesis of both …

Delayed surgery is associated with worse lung cancer outcomes. Social determinants can
influence health disparities. This study aimed to examine the potential racial disparity and …

This article reviews the available literature on racial, sex, sexual identity, age, disability,
socioeconomic, and geographic disparities in lung cancer diagnosis, treatment, and …

Background Nonsmall‐cell lung cancer (NSCLC) is a common diagnosis among patients
living in rural areas and small towns who face unique challenges accessing care. We …

Background: Limited data exist on the impact of immunotherapy use in ethnic minority
patients with non–small cell lung cancer (NSCLC), because they have been …

Background Adjuvant chemotherapy (AC) is recommended since 2004 for patients with a
completely resected non-small cell lung cancer (NSCLC). Indeed, several randomized …

Background Previous studies investigating whether metastatic lymph node count is a
relevant prognostic factor in pathological N1 non-small cell lung cancer (NSCLC), showed …